Search Results
Aug 19, 2026, 09:37 ET WERFEN RECEIVES 2026 IMV ServiceTrak™ AWARDS FOR BEST CUSTOMER SATISFACTION, SYSTEM PERFORMANCE AND SERVICE IN COAGULATION
day," said Richa Singh, VP Strategic Insights, at IMV, part of Science and Medicine Group. "These awards are grounded in independent, data-driven research, which makes them one of the most credible benchmarks in the industry."Werfen Receives 2026 IMV ServiceTrak Awards for Best Customer Satisfaction,
More news about: Werfen
Aug 07, 2026, 14:10 ET bioMérieux Highlights Positive Impacts of Rapid, Accurate Diagnostics for Patients and Accepts Industry Awards at ADLM 2026
(ADLM) Annual Conference & Clinical Lab Expo for an important conversation about the impact of access to diagnostics while also accepting multiple IMV ServiceTrak™ awards.
More news about: bioMérieux
Jul 21, 2026, 08:30 ET The Second Battlefield for Solid Tumor CAR-T: A Global Race in the Intracranial Arena -- Who Is Leading?
vivo CAR-TImmunofoco / IMV103Gastric cancer
More news about: T-MAXIMUM PHARMACEUTICAL
Apr 20, 2026, 08:18 ET 2026 AACR：易慕峰生物IMV102體內CAR-T實現持久腫瘤控制，臨床前數據發佈
IFN-γ水平均處於可控範圍內，體現出免疫活性與安全性的良好平衡。易慕峰生物董事長&CEO孫敏敏博士表示：「IMV102的積極進展進一步驗證了公司『體外CAR-T + 體內CAR-T』雙引擎戰略的前瞻性與可行性。體內CAR-T
More news about: 易慕峰生物
Apr 20, 2026, 06:07 ET Immunofoco Presents Preclinical Data for IMV102, an In Vivo CAR-T Candidate, Demonstrating Durable Tumor Control at the AACR 2026
Immunofoco today announced the presentation of new preclinical data for its in vivo BCMA-targeting CAR-T candidate, IMV102, at the AACR Annual Meeting 2026. The data demonstrate that IMV102 achieved potent and durable anti-tumor activity in multiple myeloma models, highlighting its potential to address
More news about: Immunofoco
Feb 13, 2026, 10:45 ET Veterinary Ultrasound Market worth $0.65 billion by 2031 | MarketsandMarkets™
SAMSUNG (South Korea), VINNO Technology (Suzhou) Co., Ltd. (China), Butterfly Network, Inc. (US), CHISON Medical Technologies Co., Ltd. (China), and IMV Imaging (UK), among others.Browse Adjacent Markets:
More news about: MarketsandMarkets
Jan 29, 2026, 07:30 ET Cars.com Launches Powerful New Solutions, Helping Dealers Turn Smarter Technology into Real Profit
www.carscommerce.inc. ¹ Cars Commerce Pilot Results for VIN specific video creative in IMV campaigns with limited test group Q2-Q3 2025² Cars Commerce Consumer Survey of Recent Car Buyers, Oct 2025, N=259³ Market
More news about: Cars.com Inc.
Jan 13, 2026, 03:26 ET Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ
in March 2025. The IMC008 (SNR CAR-T) product has rapidly moved to the IIT stage and received two ODD approvals from the U.S. FDA in August 2023. IMV101（in vivo CAR-T）has also rapidly moved to the IIT stage.In August 2022, we successfully completed the construction validation of our nearly 2500m2
More news about: Immunofoco Biotechnology
Nov 26, 2025, 12:01 ET Devonian Health Group Reports its Fourth Quarter and Annual 2025 Financial Results and Appointment of a New Board Member
treasury, and risk management.Prior to joining Fonds QScale S.E.C., Mr. Labbé served for five years as Chief Financial Officer ("CFO") of IMV Inc. He also previously held the positions of CFO and Corporate Secretary at LeddarTech Inc. and Medicago Inc. ("TSX"). In addition, Mr. Labbé
More news about: Devonian Health Group Inc.
Oct 09, 2025, 17:31 ET Platinum-Resistant Ovarian Cancer Treatment Market Sees Momentum with Next-Generation Targeted Strategies | DelveInsight
Oncology, Gradalis, AbbVie, Elevation oncology, OncoQuest Pharmaceuticals (CanariaBio), Alkermes, Hoffman-la Roche, AstraZeneca, MSD, GlaxoSmithKline, IMV, Corcept Therapeutics, among others.
More news about: DelveInsight Business Research, LLP
Sep 29, 2025, 08:00 ET BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")
The APA Formalized the February 2024 BioVaxys Acquisition of the Former IMV Inc. Assets VANCOUVER, BC, Sept. 29, 2025 /PRNewswire/
More news about: BioVaxys Technology Corp.